US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kardigan

13.83

+0.34002.52%

Volume:1.03M

Turnover:14.03M

Market Cap:1.29B

PE:-4.48

High:14.19

Open:13.34

Low:12.23

Close:13.49

52wk High:27.00

52wk Low:12.23

Shares:93.50M

Float Shares:23.33M

Volume Ratio:1.33

T/O Rate:4.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0900

EPS(LYR):-14.8367

ROE:--

ROA:--

PB:2.10

PE(LYR):-0.93

Loading ...

Overview Company News Filings

KARD’s Danicamtiv Trial Progress Puts Genetic Heart Failure in Investor Focus

Kardigan Files Form 3 for Director Kristin Marie K Reinke

Kardigan Announces Appointment of Kristin Reinke to Its Board of Directors

THOMSON REUTERS

Kardigan to Present at Cantor Global Healthcare Conference Fireside Chat

Kardigan’s Tonlamarsen Trial Targets Severe Hypertension: What Investors Should Watch

Kardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ Radar

Kardigan Price Target Cut to $46.00/Share from $51.00 by JP Morgan

Kardigan price target lowered to $46 from $51 at JPMorgan

Kardigan Q2 EPS $(4.61) Misses $(0.71) Estimate

Benzinga Earnings

Kardigan Q2 Per-Share Loss Narrows

MT Newswires Live

Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share

MT Newswires Live

Kardigan reports Q2 EPS ($4.61) vs ($4.64) last year

Kardigan Q2 FY26 Net Loss Widens to $116.24 Million; R&D Expenses Rise to $56.37 Million

Kardigan - Q2 Net Loss was $116.20 Mln

THOMSON REUTERS

Press Release: Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates

TD Cowen Initiates Kardigan at Buy With $46 Price Target

MT Newswires Live

Leerink Partners Initiates Kardigan at Outperform With $37 Price Target

MT Newswires Live

Kardigan Initiated at Buy by Jefferies

Kardigan initiated with an Overweight at JPMorgan

Kardigan initiated with a Buy at Jefferies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/KARD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KARD\",,,,,undefined,":{"symbol":"KARD","market":"US","secType":"STK","nameCN":"Kardigan","latestPrice":13.83,"timestamp":1791403200000,"preClose":13.49,"halted":0,"volume":1025706,"delay":0,"changeRate":0.025203854707190502,"floatShares":23333300,"shares":93503699,"eps":-3.09,"marketStatus":"Pre-Mkt","change":0.34,"latestTime":"10-08 09:12:22 EDT","open":13.34,"high":14.19,"low":12.23,"amount":14033996.68968,"amplitude":0.145293,"askPrice":18.29,"askSize":100,"bidPrice":10.98,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.09,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"listingDate":1781755200000,"exchange":"NASDAQ","adjPreClose":13.83,"postHourTrading":{"tag":"盘后","latestPrice":13.83,"preClose":13.83,"latestTime":"19:30 EDT","volume":50,"amount":691.5,"timestamp":1791415802531,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3258922480530693,"impliedVol":0.7646,"impliedVolPercentile":0.8182},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KARD\",,,,,undefined,":{"symbol":"KARD","floatShares":23333300,"roa":"--","roe":"--","lyrEps":-14.836702,"volumeRatio":1.3258922480530693,"shares":93503699,"dividePrice":0,"high":14.19,"amplitude":0.145293,"preClose":13.49,"low":12.23,"week52Low":12.23,"pbRate":"2.10","week52High":27,"institutionHeld":0,"latestPrice":13.83,"eps":-3.09,"divideRate":0,"volume":1025706,"delay":0,"ttmEps":-3.09,"open":13.34,"prevYearClose":16,"prevWeekClose":14.79,"prevMonthClose":14.75,"prevQuarterClose":14.75,"fiveDayClose":14.75,"twentyDayClose":19.68,"sixtyDayClose":22.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KARD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KARD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KARD","date":"2026-10-07","current":-4.475728,"percent":1,"low":-10.060668,"twenty":-8.640521,"median":-7.09735,"eighty":-5.918128,"high":-4.367849,"avg":-7.24912,"sd":1.521452,"marketCap":1261364899},"quantilePoints":[{"date":"2026-06-26","current":-8.771038,"twenty":-8.785799,"median":-8.638967,"eighty":-8.555064,"marketCap":2017277352},{"date":"2026-07-02","current":-9.365355,"twenty":-9.304758,"median":-8.844842,"eighty":-8.606338,"marketCap":2153966207},{"date":"2026-07-10","current":-9.497426,"twenty":-9.402646,"median":-9.202209,"eighty":-8.63586,"marketCap":2184341508},{"date":"2026-07-17","current":-8.165067,"twenty":-9.402646,"median":-9.140059,"eighty":-8.601677,"marketCap":1877908323},{"date":"2026-07-24","current":-8.417555,"twenty":-9.304758,"median":-8.862322,"eighty":-8.544187,"marketCap":1935978752},{"date":"2026-07-31","current":-7.951424,"twenty":-9.261253,"median":-8.708887,"eighty":-8.273054,"marketCap":1828771806},{"date":"2026-08-07","current":-7.908695,"twenty":-9.248823,"median":-8.631199,"eighty":-8.113793,"marketCap":1818944503},{"date":"2026-08-14","current":-7.061734,"twenty":-9.209201,"median":-8.551568,"eighty":-7.960747,"marketCap":2039315675},{"date":"2026-08-21","current":-6.559868,"twenty":-9.156374,"median":-8.417555,"eighty":-7.800708,"marketCap":1894384941},{"date":"2026-08-28","current":-6.734712,"twenty":-9.043725,"median":-8.227218,"eighty":-7.055906,"marketCap":1944876939},{"date":"2026-09-04","current":-6.715284,"twenty":-8.891455,"median":-8.165067,"eighty":-6.786517,"marketCap":1939266717},{"date":"2026-09-11","current":-6.051527,"twenty":-8.87281,"median":-8.087379,"eighty":-6.755434,"marketCap":1747584134},{"date":"2026-09-18","current":-5.403958,"twenty":-8.830081,"median":-7.955309,"eighty":-6.659593,"marketCap":1560576736},{"date":"2026-09-25","current":-4.659255,"twenty":-8.746178,"median":-7.865966,"eighty":-6.491226,"marketCap":1345518228},{"date":"2026-10-02","current":-4.613925,"twenty":-8.645182,"median":-7.395233,"eighty":-6.074839,"marketCap":1332427710},{"date":"2026-10-07","current":-4.367849,"twenty":-8.640521,"median":-7.09735,"eighty":-5.918128,"marketCap":1261364899}],"updateTime":1791465142061},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KARD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673308651","title":"KARD’s Danicamtiv Trial Progress Puts Genetic Heart Failure in Investor Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2673308651","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673308651?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:30","pubTimestamp":1791217813,"startTime":"0","endTime":"0","summary":"Kardigan, Inc. ($KARD) announced an update on their ongoing clinical study. Kardigan, Inc. (KARD) is running a late‑stage study to test danicamtiv ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kards-danicamtiv-trial-progress-puts-genetic-heart-failure-in-investor-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kards-danicamtiv-trial-progress-puts-genetic-heart-failure-in-investor-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","KARD","BK4097","BK4007","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672207767","title":"Kardigan Files Form 3 for Director Kristin Marie K Reinke","url":"https://stock-news.laohu8.com/highlight/detail?id=2672207767","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672207767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:58","pubTimestamp":1790891918,"startTime":"0","endTime":"0","summary":"Kardigan files Form 3 for director Kristin Marie K ReinkeKardigan director Kristin Marie K Reinke filed an initial Form 3 on Sept. 29, 2026.Disclaimer:This news brief was created by Public Technologie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL8fkt1n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671201392","title":"Kardigan Announces Appointment of Kristin Reinke to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2671201392","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671201392?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:00","pubTimestamp":1790769606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA4KYRJ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664493008","title":"Kardigan to Present at Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664493008","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664493008?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:06","pubTimestamp":1788379594,"startTime":"0","endTime":"0","summary":"Kardigan to present at Cantor Global Healthcare Conference fireside chatKardigan will join the 2026 Cantor Global Healthcare Conference on Sept. 9, 2026, featuring a 1:35 p.m. ET fireside chat.It will","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLl4CkH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843540","title":"Kardigan’s Tonlamarsen Trial Targets Severe Hypertension: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843540","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843540?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:30","pubTimestamp":1788366658,"startTime":"0","endTime":"0","summary":"Kardigan, Inc. ($KARD) announced an update on their ongoing clinical study. The Phase 2b study, officially titled “A Phase 2b, Randomized, Double-B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kardigans-tonlamarsen-trial-targets-severe-hypertension-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kardigans-tonlamarsen-trial-targets-severe-hypertension-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","KARD","BK4007","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664435238","title":"Kardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2664435238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664435238?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:30","pubTimestamp":1788366649,"startTime":"0","endTime":"0","summary":"Kardigan, Inc. ($KARD) announced an update on their ongoing clinical study. Kardigan, Inc. (KARD) is running a long term Phase 3 study called “An O...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kardigans-danicamtiv-heart-study-moves-forward-keeping-kard-on-investors-radar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kardigans-danicamtiv-heart-study-moves-forward-keeping-kard-on-investors-radar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4211","KARD","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662173798","title":"Kardigan Price Target Cut to $46.00/Share from $51.00 by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173798","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173798?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:06","pubTimestamp":1787663160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KARD/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662348167","title":"Kardigan price target lowered to $46 from $51 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662348167","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662348167?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659237,"startTime":"0","endTime":"0","summary":"JPMorgan lowered the firm’s price target on Kardigan (KARD) to $46 from $51 and keeps an Overweight rating on the shares. The firm updated models i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kardigan-price-target-lowered-to-46-from-51-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kardigan-price-target-lowered-to-46-from-51-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658099728","title":"Kardigan Q2 EPS $(4.61) Misses $(0.71) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658099728","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658099728?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:55","pubTimestamp":1786449342,"startTime":"0","endTime":"0","summary":"Kardigan (NASDAQ:KARD) reported quarterly losses of $(4.61) per share which missed the analyst consensus estimate of $(0.71) by 549.3 percent. This is a 0.65 percent increase over losses of $(4.64) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61104810/kardigan-q2-eps-4-61-misses-0-71-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599758","title":"Kardigan Q2 Per-Share Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599758","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599758?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:37","pubTimestamp":1786448261,"startTime":"0","endTime":"0","summary":"Kardigan (KARD) reported a Q2 GAAP loss Tuesday of $4.61 per diluted share, narrowing from a loss of $4.64 a year earlier.The company did not report revenue for the quarter.As of June 30, cash, cash equivalents and investments were $660.7 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992694","title":"Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992694","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992694?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:11","pubTimestamp":1786446708,"startTime":"0","endTime":"0","summary":"Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992479","title":"Kardigan reports Q2 EPS ($4.61) vs ($4.64) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992479?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:11","pubTimestamp":1786446688,"startTime":"0","endTime":"0","summary":"Cash, cash equivalents and investments were $660.7M as of June 30, 2026, compared to $335.5M as of December 31, 2025. “Our IPO has positioned Kardi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kardigan-reports-q2-eps-4-61-vs-4-64-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kardigan-reports-q2-eps-4-61-vs-4-64-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999478","title":"Kardigan Q2 FY26 Net Loss Widens to $116.24 Million; R&D Expenses Rise to $56.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999478","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658999478?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:01","pubTimestamp":1786446117,"startTime":"0","endTime":"0","summary":"Kardigan Q2 FY26 net loss widens to $116.24 million; R&D expenses rise to $56.37 millionKardigan posted a Q2 net loss of USD 116.24 million, widening from USD 57.45 million a year earlier.R&D expense ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLbbK3PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992879","title":"Kardigan - Q2 Net Loss was $116.20 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992879?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA8QDBPN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658799280","title":"Press Release: Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658799280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658799280?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":"directly targeting the underlying sarcomeric defects in genetic dilated. --  Danicamtiv is currently being evaluated in the Company's KINSHIP-DCM. --  Preclinical and clinical evidence linking danicamtiv treatment to. improvements in right ventricular function to be presented at the. upcoming European Society of Cardiology Congress . [Session:. Late-Breaking Basic and Translational Science; Sunday, Aug. 30th at 8:15. --  In July, the Company completed enrollment of Cohort 1 (myosin heavy. chain 7, or MYH7, and titin, or TTN, patients) of the Phase 2b. KINSHIP-DCM clinical trial and enrollment of the Phase 3 portion is now. underway. The Company expects to share Phase 2b topline data in the first. half of 2027.Ataciguat: soluble guanylate cyclase  activator in development for CAVS--  Ataciguat targets valvular interstitial cells to slow osteogenic and. calcific remodeling, an underlying driver of disease progression in. calcific aortic valve stenosis , and has demonstrated direct. myoca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYLG","IDNA","03160","AGT","KARD","BK4109","BK4099","BK4585","LU2463526074.USD","MEDX","BK4007","GDOC","BK4555","ASH","NVIB","BK4604","BK4588","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651635116","title":"TD Cowen Initiates Kardigan at Buy With $46 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2651635116","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651635116?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:28","pubTimestamp":1783942089,"startTime":"0","endTime":"0","summary":"TD Cowen Initiates Kardigan at Buy With $46 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KARD","COWN","TD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115088","title":"Leerink Partners Initiates Kardigan at Outperform With $37 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115088","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115088?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:12","pubTimestamp":1783941126,"startTime":"0","endTime":"0","summary":"Leerink Partners Initiates Kardigan at Outperform With $37 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651152551","title":"Kardigan Initiated at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2651152551","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651152551?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:04","pubTimestamp":1783940640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KARD/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 07:04 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190950","title":"Kardigan initiated with an Overweight at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651190950?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:35","pubTimestamp":1783935310,"startTime":"0","endTime":"0","summary":"JPMorgan initiated coverage of Kardigan (KARD) with an Overweight rating and $51 price target The firm sees each of Kardigan’s mid-stage cardiovasc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kardigan-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kardigan-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KARD","JPM","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190992","title":"Kardigan initiated with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190992","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651190992?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:35","pubTimestamp":1783935305,"startTime":"0","endTime":"0","summary":"Jefferies initiated coverage of Kardigan (KARD) with a Buy rating and $40 price target The firm sees “value creating catalysts” for the company’s t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kardigan-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kardigan-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}